BRIEF published on 04/24/2026 at 07:35, 4 months 19 days ago Evotec annonce la transition du directeur financier Evotec Leadership Financier Transition Du Directeur Financier Paul Hitchin Claire Hinshelwood
BRIEF published on 04/24/2026 at 07:35, 4 months 19 days ago AFYREN Secures €3 Million Grant from Grand Est Region Geopolitical Impact AFYREN Just Transition Fund Biorefinery Investment Bio-based Solutions
BRIEF published on 04/24/2026 at 07:35, 4 months 19 days ago AFYREN obtient une subvention de 3 millions d'euros de la région Grand Est Impact Géopolitique AFYREN Fonds Pour Une Transition Juste Investissement Dans Les Bioraffineries Solutions Biosourcées
BRIEF published on 04/24/2026 at 07:35, 4 months 19 days ago AFYREN bénéficie de 3 M€ pour sa transition écologique Transition Écologique Subvention AFYREN Fonds Européen Biosourcé
BRIEF published on 04/24/2026 at 07:35, 4 months 19 days ago AFYREN receives €3 million for its ecological transition Grant Ecological Transition AFYREN European Fund Bio-based
BRIEF published on 04/24/2026 at 07:05, 4 months 19 days ago INFICON Reports Robust Q1 2026 Performance and Raises Guidance Financial Guidance Sales Increase First Quarter Results Semiconductor Market Operational Margin
BRIEF published on 04/24/2026 at 07:05, 4 months 19 days ago INFICON annonce des résultats solides pour le premier trimestre 2026 et relève ses prévisions. Marge Opérationnelle Conseils Financiers Marché Des Semi-conducteurs Résultats Du Premier Trimestre Augmentation Des Ventes
BRIEF published on 04/24/2026 at 07:05, 4 months 19 days ago BB Biotech AG Reports Q1 2026 Interim Results Drug Development Net Loss Investment Portfolio BB Biotech Q1 2026
BRIEF published on 04/24/2026 at 07:05, 4 months 19 days ago BB Biotech AG publie ses résultats intermédiaires du premier trimestre 2026 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech 1er Trimestre 2026
BRIEF published on 04/24/2026 at 07:05, 4 months 19 days ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
Published on 09/12/2026 at 02:35, 1 day 11 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 14 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 16 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 20 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 19 hours 51 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 6 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 15 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 15 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 17 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 18 hours ago Availability of the 2026 Interim Financial Report
